Top Banner
Ophthalmology Grand Rounds Unilateral Superior Field Loss September 8, 2009 Michele Todman, MD
29
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Susac Syndrome

Ophthalmology Grand Rounds

Unilateral Superior Field Loss

September 8, 2009

Michele Todman, MD

Page 2: Susac Syndrome

HistoryHPI: 16 y/o female

● Painless superior visual field loss OS● Encephalitis● viral illness 3 weeks prior

PMH:negative

ROS: (-)weakness, numbness,fatigue, incontinence, L’Hermitte’s sign

Meds: NoneFH: Noncontributory

Page 3: Susac Syndrome

Initial Examination

Va: 20/20 OU

Pupils: 4mm, RRL OU, No RAPD

Motility: Full OU

Confrontation VF: Superior defect OS; Full OD

Color Plates: 12/12 OU

SLE: WNL OU

DFE: WNL OU

Page 4: Susac Syndrome

Initial HVF 24-2

Page 5: Susac Syndrome

Initial MRI

Page 6: Susac Syndrome
Page 7: Susac Syndrome

MRI

Small foci of restricted diffusion in body/splenium of corpus callosum and right external and internal capsule

No enhancement associated with lesions

Page 8: Susac Syndrome

Labs and CSF

• CBC wnl

• CSF- High protein, 194mg/dl

• CSF- High IgG index, 15.4mg/dl

• CSF- High IgG synthesis rate 13.9mg/24h

• Negative CSF and serology for infectious etiology

Page 9: Susac Syndrome

DDx

• ADEM- Acute Disseminated Encephalomyelitis– Abnormal immunologic reaction to virus including

production of Ab’s that cross-react with myelin. Occurs in children and young adults. White and gray matter lesions.

• Optic Neuritis/ MS– Immune mediated demyelination of optic nerve and

white matter lesions (latter indicate likelihood to develop MS)

Treatment at initial presentation:IV methylprednisolone 30mg/kg/day for 5 days

Page 10: Susac Syndrome

Interim Visit 2 weeks after:- MRI-Decreased size of white matter lesions in

corpus callosum. Resolving ADEM.

3 Months after Initial Presentation:

- New onset hearing loss

- Stable left eye superior visual field loss & memory trouble/encephalitis

Page 11: Susac Syndrome

What is your DDx now?

Page 12: Susac Syndrome

Color Fundus Photos

Page 13: Susac Syndrome
Page 14: Susac Syndrome
Page 15: Susac Syndrome

FA

Page 16: Susac Syndrome

Susac’s Syndrome

Page 17: Susac Syndrome

Presentation

• Triad of microangiopathy (97%-not full triad at onset. Many patients weeks to years)– Brain: Encephalopathy – Retina: Branch retinal artery occlusion

(microangiopathy-only precapillary arterioles <100 microns) associated with Gass plaques.

– Cochlea: Hearing Loss (cochlear and semicircular canal involvement)

• Female predominance 3:1• Age range 9-70 y/o but usually affects 20-40 y/o• 100 cases reported worldwide but often

misdiagnosed

Page 18: Susac Syndrome

Pathogenesis

• Autoimmune endotheliopathy• Damaged endothelial cells cause platelet

aggregation and can block blood flow. Hyaline thrombi are seen at autopsy in terminal arterioles and capillaries.

Page 19: Susac Syndrome

Pathogenesis

– FA staining/leakage localizes site of immune attack to endothelium of precapillary arteriole (< 100 microns), a site that consists primarily of endothelium and basement membrane.

– All clotting factors except factor VIII are produced in the liver.

– Factor VIII and Von Willebrand factor are produced by endothelial cells.

– Elevation of factor VIII and Von Willebrand factor Antigen reflect endothelium perturbation.

Page 20: Susac Syndrome

Labs and CSF

• Factor VIII- High, 184%

• Von Willebrand’s Antigen, High, >200%

• SLE testing all negative

• CSF- High spinal fluid protein, 194mg/dl

• CSF- High IgG index, 15.4mg/dl

• CSF- High IGg synthesis rate 13.9mg/24h

Page 21: Susac Syndrome
Page 22: Susac Syndrome
Page 23: Susac Syndrome

Retinal Artery Wall Plaques in Susac Syndrome (4 patients)

Egan, Gass et al., Am J Ophthal 2003

• Reflect endothelium damage, atheromatous plaque develops at site of acute retinal arterial damage

• Yellow or yellow-white and nonrefractile, partly or completely surround blood column

• DDx of Gass plaques- Arterial macroaneurysms, Toxoplasmic retinitis, acute retinal necrosis; can be found at sites where previous emboli have lodged

• Pay attention to color and location– Hollenhorst - orange and refractile– platelet-fibrin - gray-white– calcium plaques - chalk white Emboli - located at retinal bifurcations

Page 24: Susac Syndrome

Imaging & FA

• MRI/MRA findings– Central corpus callosal involvement, vs. peripheral involvement

with MS and ADEM– Leptomeningeal enhancement in 33%- not with MS or ADEM– Deep gray matter involvement (basal ganglia and thalamus)

70%– Gray matter lesions rare in MS, common in pediatric ADEM

• FA– BRAO acutely– Multifocal fluorescence of branch arterioles (pre-occlusive

lesions)– Peripheral retinal arterial wall occlusion

Page 25: Susac Syndrome

Callosum “holes”- develop as acute callosal changes resolve

(MS/ADEM - different distribution)

Page 26: Susac Syndrome

Clinical Course

• Lasts from 6 months- 4 years• Some have full recovery, others profound

impairment with cognitive deficits, gait disturbance, and hearing loss

• Usually vision not seriously impaired• When diagnosis and treatment are delayed-

permanent morbidity is higher in terms of neurologic deficit, visual loss, and hearing loss

Page 27: Susac Syndrome

Treatment

• IV methylprednisolone, followed by oral steroids in conjunction with cyclophosphamide or immunoglobulin seem helpful

Page 28: Susac Syndrome

Back to Our Patient

• IV Solumedrol x 3 days with IVIG x 3 days

• 60mg Prednisone x 28 days and taper

• Cyclophosphamide every 2 weeks for 6 months

• ASA 325mg daily

Page 29: Susac Syndrome

Conclusion

• Susac syndrome: triad of encephalopathy, BRAO, and deafness

• MRI of brain: central corpus callosal involvement, both white and gray matter lesions

• Fundus exam: Look for Gass plaques• Labs: Check VWF Ag and factor VIII• Obtain audiogram even if no obvious hearing

loss